Virulence properties of multidrug resistant ocular isolates of acinetobacter baumannii

Current Eye Research

Volumn 39, Issue 7, 2014, Pages 695-704

  Talreja, Deepa ^a,b   Muraleedharan, Chithra ^b   Gunathilaka, Gayathri ^a   Zhang, Yifan ^a   Kaye, Keith S ^c   Walia, Satish K ^b   Kumar, Ashok ^a,b,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b OAKLAND UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

A. baumannii; Adherence; Biofilm; Corneal epithelium; Multidrug resistant; Ocular infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; CRYSTAL VIOLET; GENTAMICIN; IMIPENEM; LACTATE DEHYDROGENASE; MEROPENEM; MOXIFLOXACIN; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL EYE INFECTION; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM CONJUGATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOFILM; CELL CULTURE; CELL DEATH; CLONAL VARIATION; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOTOXICITY; ENZYME ASSAY; ENZYME RELEASE; EPITHELIUM CELL; ESCHERICHIA COLI; FEMALE; GENE TRANSFER; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFANT; INTERNALIZATION; MALE; MICROBIOLOGY TEST; MULTIDRUG RESISTANCE; NEWBORN; NICK END LABELING; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPECIES INVASION; VERY ELDERLY; ACINETOBACTER INFECTIONS; APOPTOSIS; BACTERIAL COUNT; DRUG EFFECTS; EYE INFECTIONS, BACTERIAL; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; RETROSPECTIVE STUDY; VIRULENCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; APOPTOSIS; BIOFILMS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPITHELIUM, CORNEAL; EYE INFECTIONS, BACTERIAL; HUMANS; IN SITU NICK-END LABELING; RETROSPECTIVE STUDIES; VIRULENCE;

EID: 84901844737     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.873055     Document Type: Article

References (47)

1. Howard A, O'Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence 2012;3:243-250.
2. Antunes LC, Imperi F, Carattoli A, Visca P. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One 2011;6:e22674.
3. Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, Kaye KS. Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Diss 2010;50: 1611-1616.
4. Huang XZ, Chahine MA, Frye JG, Cash DM, Lesho EP, Craft DW, et al. Molecular analysis of imipenem-resistant Acinetobacter baumannii isolated from US service members wounded in Iraq, 2003-2008. Epidemiol Infect 2012;140: 2302-2307.
5. Wang Y, Hao P, Lu B, Yu H, Huang W, Hou H, et al. Causes of infection after earthquake, China, 2008. Emerg Infect Dis 2010;16:974-975.
6. CDC. Antibiotic resistance threats in the United States. 2013.
7. Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 2013;11:297-308.
8. Chen KJ, Hou CH, Sun MH, Lai CC, Sun CC, Hsiao CH. Endophthalmitis caused by Acinetobacter baumannii: report of two cases. J Clin Microbiol 2008;46:1148-1150.
9. Kau HC, Tsai CC, Kao SC, Hsu WM, Liu JH. Corneal ulcer of the side port after phacoemulsification induced by Acinetobacter baumannii. J Cataract Refract Surg 2002;28: 895-897.
10. Lipshy KA, Wheeler WE, Denning DE. Ophthalmic thermal injuries. Am Surgeon 1996;62:481-483.
11. Bouchard CS, Morno K, Perkins J, McDonnell JF, Dicken R. Ocular complications of thermal injury: a 3 year retrospective. J Trauma Inj Infect Crit Care 2001;50:79-82.
12. Smith SB, Coffee T, Yowler C, Steinemann TL. Risk factors for ophthalmic complications in patients with burns. J Burn Care Res 2010;31:911-917.
13. McHugh J, Alexander P, Kalhoro A, Ionides A. Screening for ocular surface disease in the intensive care unit. Eye (Lond) 2008;22:1465-1468.
14. Parkin B, Turner A, Moore E, Cook S. Bacterial keratitis in the critically ill. Brit J Ophthalmol 1997;81:1060-1063.
15. Reddy T, Chopra T, Marchaim D, Pogue JM, Alangaden G, Salimnia H, et al. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob Agents Chemother 2010;54: 2235-2238.
16. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005;43:4328-4335.
17. Yi H, Cho YJ, Yong D, Chun J. Genome sequence of Escherichia coli J53, a reference strain for genetic studies. J Bacteriol 2012;194:3742-3743.
18. Perez LR, Barth L. Biofilm production using distinct media and antimicrobial susceptibility profile of Pseudomonas. Braz J Infect Dis 2011;15:301-304.
19. Yang JL, Wang JT, Lauderdale TL, Chang SC. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production. J Microbiol Immunol Infect 2009;42:310-316.
20. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gelelectrophoresis - criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
21. Cerqueira GM, Peleg AY. Insights into Acinetobacter baumannii Pathogenicity. IUBMB Life 2011;63:1055-1060.
22. Rodriguez-Bano J, Marti S, Soto S, Fernandez-Cuenca F, Cisneros JM, Pachon J, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect 2008;14:276-278.
23. Brossard KA, Campagnari AA. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect Immun 2012;80:228-233.
24. Kochan T, Singla A, Tosi J, Kumar A. Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus. Infect Immun 2012;80:2076-2088.
25. Cavet ME, Harrington KL, VanDerMeid KR, Ward KW, Zhang J-Z. Comparison of the effect of multipurpose contact lens solutions on the viability of cultured corneal epithelial cells. Cont Lens Anterior Eye 2009;32:171-175.
26. Sheng WH, Liao CH, Lauderdale TL, Ko WC, Chen YS, Liu JW, et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis 2010;14:e764-e769.
27. Thom KA, Johnson JK, Lee MS, Harris AD. Environmental contamination because of multidrug-resistant Acinetobacter baumannii surrounding colonized or infected patients. Am J Infect Control 2011;39:711-715.
28. Mela EK, Drimtzias EG, Christofidou MK, Filos KS, Anastassiou ED, Gartaganis SP. Ocular surface bacterial colonisation in sedated intensive care unit patients. Anaesth Intensive Care 2010;38:190-193.
29. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007;51:3471-3484.
30. Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 2009;4:273-278.
31. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167-193.
32. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987;41:435-464.
33. Behlau I, Gilmore MS. Microbial biofilms in ophthalmology and infectious disease. Arch Ophthalmol 2008;126: 1572-1581.
34. Wiley L, Bridge DR, Wiley LA, Odom JV, Elliott T, Olson JC. Bacterial biofilm diversity in contact lens-related disease: emerging role of Achromobacter, Stenotrophomonas, and Delftia. Invest Ophthalmol Vis Sci 2012;53:3896-3905.
35. Liesegang TJ. Contact lens-related microbial keratitis: part II: pathophysiology. Cornea 1997;16:265-273.
36. Szczotka-Flynn LB, Pearlman E, Ghannoum M. Microbial contamination of contact lenses, lens care solutions, and their accessories: a literature review. Eye Cont Lens 2010; 36:116-129.
37. McLaughlin-Borlace L, Stapleton F, Matheson M, Dart JK. Bacterial biofilm on contact lenses and lens storage cases in wearers with microbial keratitis. J Appl Microbiol 1998;84: 827-838.
38. Stapleton F, Keay L, Edwards K, Naduvilath T, Brian G, Jacobs R. Studies of contact lens-related microbial keratitis in Australia and New Zealand: new learnings. Eye Contact Lens 2007;33:354-357;discussion 62-63.
39. Verani JR, Lorick SA, Yoder JS, Beach MJ, Braden CR, Roberts JM, et al. National outbreak of acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg Infect Dis 2009;15:1236-1242.
40. Uno T, Ohashi Y, Imayasu M. Antimicrobial efficacy tests of multipurpose contact lens care solutions simulating poor contact lens hygiene behaviors. Eye Cont Lens-Sci Clin Pract 2012;38:388-393.
41. Suzuki T, Uno T, Kawamura Y, Joko T, Ohashi Y. Postoperative low-grade endophthalmitis caused by biofilm-producing coccus bacteria attached to posterior surface of intraocular lens. J Cataract Refract Surg 2005;31: 2019-2020.
42. Aldave AJ, Stein JD, Deramo VA, Shah GK, Fischer DH, Maguire JI. Treatment strategies for postoperative Propionibacterium acnes endophthalmitis. Ophthalmology 1999;106:2395-2401.
43. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284: 1318-1322.
44. McNamara NA. Innate defense of the ocular surface. Eye Cont Lens 2003;29:S10-S13;discussion S26-S29, S192-S194.
45. Lemp MA, Blackman HJ. Ocular surface defense mechanisms. Ann Ophthalmol 1981;13:61-63.
46. Lee HW, Koh YM, Kim J, Lee JC, Lee YC, Seol SY, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect 2008;14:49-54.
47. Doi Y, Onuoha EO, Adams-Haduch JM, Pakstis DL, McGaha TL, Werner CA, et al. Screening for Acinetobacter baumannii colonization by use of sponges. J Clin Microbiol 2011;49:154-158.